PROTAC BTK Degrader-9
Product Specifications
Target
RANKL/RANK|||BTK|||PROTACs
Related Pathways
PROTAC|||Tyrosine Kinase/Adaptors|||NF-?B|||Angiogenesis
Bioactivity
PROTACBTK Degrader-9 (compound 23) is a potent PROTACs degrader that specifically targets BTK. It effectively downregulates the RANKL-activated BTK-PLC?2-Ca2+-NFATc1 signaling pathway. Consequently, PROTACBTK Degrader-9 inhibits osteoclastogenesis and reduces alveolar bone resorption in a mouse model of periodontitis.
Molecular Formula
C46H52FN13O5
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7024494-01 0.02 mg
Recombinant Human Outcome predictor in acute leukemia 1 (OPA1L)
Ask
View Details 
MBS7024494-02 0.1 mg
Recombinant Human Outcome predictor in acute leukemia 1 (OPA1L)
Ask
View Details MBS7024494-03 5x 0.1 mg
Recombinant Human Outcome predictor in acute leukemia 1 (OPA1L)
Ask
View Details 
MBS7012254-01 0.02 mg
Recombinant Choristoneura occidentalis Cytochrome c oxidase subunit 2 (COII)
Ask
View Details MBS7012254-02 0.1 mg
Recombinant Choristoneura occidentalis Cytochrome c oxidase subunit 2 (COII)
Ask
View Details MBS7012254-03 5x 0.1 mg
Recombinant Choristoneura occidentalis Cytochrome c oxidase subunit 2 (COII)
Ask
View Details